Proliferative vitreoretinopathy
1 paper1 finding
- Humans1
Associations
1Statins
downin humans1OR 0.7
1 study
Statins
downin humans1OR 0.7
Statins lower the risk of proliferative vitreoretinopathy in humans (OR 0.70, 95% CI: 0.66 to 0.75).
“statin use was independently associated with a decreased likelihood of PVR (odds ratio: 0.70, 95% CI: 0.66 to 0.75).”
Humansundergoing rhegmatogenous retinal detachment repairn = 54,876
Ophthalmic surgery, lasers & imaging retina29 Jul 2026
Trial sponsors
Shahid Beheshti University of Medical Sciences
2 trialsPhase 374 people
1 trialPhase 2/380 people
Cincinnati Eye Institute, Southwest Ohio
1 trialPhase 2860 people
University of Health Sciences Lahore
1 trialPhase 1/2120 people
Latest
1 in 12 monthsOphthalmic Surgery, Lasers & Imaging Retina
Statin Use and the Risk of Proliferative Vitreoretinopathy in Eyes Undergoing Rhegmatogenous Retinal Detachment Repair
Cohort study of 54,876 peopleEye